Form: 6-K

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

May 28, 2015

Exhibit 99.4
 
 
 
KPMG LLP 
600 de Maisonneuve Blvd. WestSuite 1500
Tour KPMG
Montréal (Québec)  H3A 0A3
 
 
Telephone (514) 840-2100
Fax(514) 840-2187
Internetwww.kpmg.ca
 
 
 
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM
 
 
The Board of Directors
 
Acasti Pharma Inc.
 
We consent to the incorporation by reference in the Registration Statement (File No. 333-191907) on Form F-10 and Registration Statement (File No. 333-191383) on Form S-8 of Acasti Pharma Inc. of our report dated May 27, 2015, on the financial statement which comprise the  statements of financial position as at February 28, 2015 and 2014, the  statements of earnings and comprehensive loss, changes in equity and cash flows for each of the years in the three-year period ended February 28, 2015, and notes, comprising a summary of significant accounting policies and other explanatory information, which report appears on Form 6-K of Acasti Pharma Inc.
 
 
May 27, 2015
 
Montreal, Canada
 
 
 
 
 
 
 
*CPA auditor, CA, public accountancy permit No. A119178
 
KPMG LLP is a Canadian limited liability partnership and a member firm of the KPMG
 
network of independent member firms affiliated with KPMG International Cooperative
 
("KPMG International"), a Swiss entity.
 
KPMG Canada provides services to KPMG LLP.